首页> 美国卫生研究院文献>Cancer Medicine >Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II‐IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort

【2h】

Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II‐IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort

机译：建立并验证两个诺模图以预测具有不同危险因素的II-IVa期鼻咽癌患者同时进行化疗的益处：基于大量队列的分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

We aimed to establish and validate two nomograms that predict progression‐free survival (PFS) and overall survival (OS) in patients with stage II–IVa nasopharyngeal carcinoma (NPC) while evaluating the benefit of concurrent chemotherapy.

机译：我们旨在建立和验证两个诺法图，以预测II–IVa期鼻咽癌（NPC）患者的无进展生存期（PFS）和总体生存期（OS），同时评估同时化疗的益处。

著录项

期刊名称 Cancer Medicine
作者
Xue‐Song Sun; Bei‐Bei Xiao; Chao Lin; Sai‐Lan Liu; Qiu‐Yan Chen; Lin‐Quan Tang; Hai‐Qiang Mai;
展开▼
作者单位

展开▼
年(卷),期 2020(9),5
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
concurrent chemotherapy; nasopharyngeal carcinoma; nomogram; radiotherapy; survival;

机译：并发化疗;鼻咽癌;列线图;放疗;生存;

相似文献

外文文献
中文文献
专利

1. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II‐IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort [J] . Xue‐Song Sun, Bei‐Bei Xiao, Chao Lin, Cancer Medicine . 2020,第5期

机译：建立和验证两种载体，以预测不同风险因素阶段II-IVA鼻咽癌患者同时化疗的益处：基于大队列的分析
2. Establishment and validation of a nomogram for predicting the benefit of concurrent chemotherapy in stage II nasopharyngeal carcinoma: A study based on a phase III randomized clinical trial with 10-year follow-up [J] . Sun Xue-Song, Li Xiao-Yun, Xiao Bei-Bei, Oral oncology . 2020,第期

机译：建立和验证预测阶段鼻咽癌同时化疗的益处：基于AII期随机临床试验的研究，10年随访
3. A novel scoring model to predict benefit of additional induction chemotherapy to concurrent chemoradiotherapy in stage II–IVa nasopharyngeal carcinoma [J] . Liang Peng, Yu-Pei Chen, Cheng Xu, Oral oncology . 2018,第期

机译：一种新的评分模型，以预测额外的诱导化疗与同时IVA鼻咽癌同时化学疗法的益处
4. Applying Quantitative Adiposity Feature Analysis Models to Predict Benefit of Bevacizumab-based Chemotherapy in Ovarian Cancer Patients [C] . Yunzhi Wang, Yuchen Qiu, Theresa Thai, Conference on medical imaging . 2016

机译：应用定量肥胖特征分析模型预测基于贝伐单抗的卵巢癌化疗获益
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma [O] . Sai-Lan Liu, Xue-Song Sun, Zi-Jian Lu, 2020

机译：预测在阶段II-IVB鼻咽癌中在阶段IVB鼻咽癌诱导化疗后将同时化疗添加到强度调制放射的益处
7. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II‐IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort [O] . Xue‐Song Sun, Bei‐Bei Xiao, Chao Lin, 2020

机译：建立和验证两种载体，以预测不同风险因素阶段II-IVA鼻咽癌患者同时化疗的益处：基于大队列的分析

Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II‐IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort

摘要

著录项

相似文献

相关主题

期刊订阅